These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1783996)

  • 1. Mean residence time of drugs in pharmacokinetic systems with linear distribution, linear or nonlinear elimination, and noninstantaneous input.
    Cheng HY; Jusko WJ
    J Pharm Sci; 1991 Oct; 80(10):1005-6. PubMed ID: 1783996
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
    Cheng HY; Jusko WJ
    Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear mixed-effects models for pharmacokinetic data analysis: assessment of the random-effects distribution.
    Drikvandi R
    J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):223-232. PubMed ID: 28194555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems dynamics in clinical pharmacokinetics. An introduction.
    van Rossum JM; de Bie JE
    Clin Pharmacokinet; 1989 Jul; 17(1):27-44. PubMed ID: 2663303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single pass mean residence time in peripheral tissues: a distribution parameter intrinsic to the tissue affinity of a drug.
    Veng-Pedersen P; Gillespie WR
    J Pharm Sci; 1986 Dec; 75(12):1119-26. PubMed ID: 3559920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncompartmentally-based pharmacokinetic modeling.
    Veng-Pedersen P
    Adv Drug Deliv Rev; 2001 Jun; 48(2-3):265-300. PubMed ID: 11369086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs.
    Watari N; Benet LZ
    J Pharmacokinet Biopharm; 1989 Oct; 17(5):593-9. PubMed ID: 2614687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to pharmacokinetics in clinical toxicology.
    Vajjah P; Isbister GK; Duffull SB
    Methods Mol Biol; 2012; 929():289-312. PubMed ID: 23007434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Feb; 98(2):748-62. PubMed ID: 18506769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.
    Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO
    Br J Clin Pharmacol; 1999 Jan; 47(1):53-8. PubMed ID: 10073740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics in nonlinear and partially compartmentalized systems.
    Radziuk J
    Fed Proc; 1980 May; 39(7):2450-5. PubMed ID: 7371876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unifying concept of pharmacokinetics derived from drug distribution and elimination in renal failure.
    Keller F; Frankewitsch T; Zellner D; Simon S
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):546-9. PubMed ID: 8574504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation.
    Van Kesteren Ch; Mathôt RA; Raymond E; Armand JP; Dittrich Ch; Dumez H; Roché H; Droz JP; Punt C; Ravic M; Wanders J; Beijnen JH; Fumoleau P; Schellens JH;
    J Clin Oncol; 2002 Oct; 20(19):4065-73. PubMed ID: 12351604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stochastic interpretation of linear pharmacokinetics: a linear system analysis approach.
    Veng-Pedersen P
    J Pharm Sci; 1991 Jul; 80(7):621-31. PubMed ID: 1941557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of human volume of distribution values for drugs using linear and nonlinear quantitative structure pharmacokinetic relationship models.
    Louis B; Agrawal VK
    Interdiscip Sci; 2014 Mar; 6(1):71-83. PubMed ID: 24464707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlinear pharmacokinetics: clinical Implications.
    Ludden TM
    Clin Pharmacokinet; 1991 Jun; 20(6):429-46. PubMed ID: 2044328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.